CNBX Pharmaceuticals Inc (CNBX)
0.0098
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
CNBX Pharmaceuticals Revenue (Quarterly): 0.0406M for Feb. 29, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.0406M |
| November 30, 2023 | 0.0894M |
| August 31, 2023 | 0.10M |
| May 31, 2023 | 0.3102M |
| February 28, 2023 | |
| November 30, 2022 | |
| August 31, 2022 | 0.03M |
| May 31, 2022 | |
| February 28, 2022 | |
| November 30, 2021 | |
| August 31, 2021 | |
| May 31, 2021 | |
| February 28, 2021 | |
| November 30, 2020 | |
| August 31, 2020 | 0.0022M |
| May 31, 2020 | 0.0019M |
| February 29, 2020 | 0.0013M |
| Date | Value |
|---|---|
| November 30, 2019 | 0.0018M |
| August 31, 2019 | 0.0021M |
| May 31, 2019 | 0.0022M |
| February 28, 2019 | 0.0023M |
| November 30, 2018 | 0.0033M |
| August 31, 2018 | 0.003M |
| May 31, 2018 | 0.003M |
| February 28, 2018 | 0.0019M |
| November 30, 2017 | 0.0018M |
| August 31, 2017 | 0.0029M |
| May 31, 2017 | 0.0016M |
| February 28, 2017 | 0.0012M |
| November 30, 2016 | |
| August 31, 2016 | 0.05M |
| May 31, 2016 | 0.05M |
| February 29, 2016 | 0.0125M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0013M
Minimum
Feb 2020
0.3102M
Maximum
May 2023
0.0529M
Average
0.0022M
Median
Aug 2020
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.3255M |
| Total Expenses (Quarterly) | 0.2471M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 1.560M |
| Gross Profit Margin (Quarterly) | 84.69% |
| Profit Margin (Quarterly) | -800.9% |
| Earnings Yield | -575.2% |
| Normalized Earnings Yield | -386.60 |